sc 51089 has been researched along with Cerebral Hemorrhage in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CF; Gao, Y; Han, X; Hou, Z; Li, Q; Maruyama, T; Wang, J; Wu, H; Wu, T; Zhang, J; Zhao, X | 1 |
| Ahmad, AS; Dang, A; Doré, S; Greene, E; Leclerc, JL; Singh, N; Soshnik-Schierling, L | 1 |
2 other study(ies) available for sc 51089 and Cerebral Hemorrhage
| Article | Year |
|---|---|
Toxic role of prostaglandin E2 receptor EP1 after intracerebral hemorrhage in mice.
Topics: Alprostadil; Animals; Brain; Cerebral Hemorrhage; Female; Hydrazines; Male; Mice; Microglia; Neurons; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype | 2015 |
Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor.
Topics: Animals; Astrocytes; Blood-Brain Barrier; Brain; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Gliosis; Hydrazines; Iron; Leukocytes; Male; Mice, Inbred C57BL; Microglia; Neuroimmunomodulation; Neuroprotective Agents; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype; Recovery of Function | 2015 |